# EDGAR Filing Document

**Accession Number:** 0000091142
**File Stem:** 0000091142-26-000080
**Filing Date:** 2026-4
**Character Count:** 8328
**Document Hash:** 2fc279a264a95eb4f159d9459349e4f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000091142-26-000080.hdr.sgml**: 20260529

**ACCESSION NUMBER**: 0000091142-26-000080

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SMITH A O CORP
- **CENTRAL INDEX KEY:** 0000091142
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD APPLIANCES [3630]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 390619790
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 11270 WEST PARK PLACE
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53224
- **BUSINESS PHONE:** 4143594000

**MAIL ADDRESS:**
- **STREET 1:** 11270 WEST PARK PLACE
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53224

April 29, 2026

VIA EDGAR

Mr. Charles Eastman

Ms. Melissa Gilmore

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

**Re:&nbsp;&nbsp;&nbsp;&nbsp;A. O. Smith Corporation**

**Form 10-K for Fiscal Year Ended December 31, 2025**

**Filed February 10, 2026**

**File No. 001-00475**

Dear Mr. Eastman and Ms. Gilmore:

This letter is in response to the letter dated April, 21, 2026, from the Staff of the Division of Corporation Finance (the "Staff") of the Securities and Exchange Commission (the "SEC"), relating to the above-referenced Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Form 10-K"). The Staff's comment is set forth below in bold, followed by the Company's response to the comment.

Please note that the "Company," "A. O. Smith," "we," "us," and "our" refer to A. O. Smith and its consolidated subsidiaries, and unless the context otherwise requires, all references to page numbers correspond to the pages in the Form 10-K. All terms used but not defined herein have the meanings assigned to such terms in the Form 10-K.

***<u>Form 10-K for Fiscal Year Ended December 31, 2025</u>***

***<u>Income Taxes,</u> <u>page 50</u>***

***<u>1. Your MD&A attributes the 2025 effective tax rate change to reduced U.S. cross-border taxes, yet your rate reconciliation lacks a corresponding category. Additionally, you cite a "one-time tax adjustment" from a tax law change as a cash flow benefit, but this is not separately identified in your reconciliation as required by ASC 740-10-50-12A(a). Please tell us and disclose in future filings the details of the specific tax law change. Also, clarify how these items are currently reflected in your reconciliation and why they do not warrant separate presentation.</u>***

**<u>Company Response:</u>**

We respectfully acknowledge the Staff's comment and are providing additional details and references to identify the materiality considerations that we used when determining the items to disclose in MD&A, as well as the referenced rate reconciliation contained within Note 14, Income Taxes.

The "one-time tax adjustment" referenced as a cash flow benefit on page 23 in Liquidity and Capital Resources relates to changes to the timing of deduction of previously capitalized domestic research and development expenses under IRC Section 174 from the One Big Beautiful Bill Act. We are deducting the remaining unamortized domestic research and development costs over two years (half in 2025 and the other half in 2026). As shown in the deferred tax table of Note 14, Income Taxes, this tax adjustment reduced "Intangible" deferred tax assets and corresponding 2025 U.S. federal estimated income tax payments by approximately $13 million.

Related to our reconciliation disclosures in accordance with *ASC 740-10-50-12A(a),* please note that the one-time tax adjustment referenced above under IRC Section 174 did not have a rate impact, instead as mentioned above it offset deferred taxes and thus is not included in the reconciliation. Pertaining to U.S. cross-border taxes, we did not separately present these taxes within the rate reconciliation based on the immateriality of the amounts involved and instead included them in "Other Adjustments". The materiality considerations for U.S. cross-border taxes were made with reference to ASU 2023-09 "Improvements to Income Tax Disclosures", specifically Background Information and Basis for Conclusions ("BC") #22 (BC22):

*<u>"Materiality Considerations</u>*

*<u>BC22. A number of stakeholders requested that the Board clarify whether (and how) materiality should be considered when evaluating whether reconciling items that meet the quantitative threshold are required to be disclosed. The Board observed that the guidance in paragraph 105-10-05-6, which states that the provisions of the Codification need not be applied to immaterial items, is applicable to the amendments in this Update, as it is to all Codification guidance. Therefore, the amendments on the disclosure of reconciling items by specific categories with further disaggregation of reconciling items based on the application</u>*

------

*<u>of a quantitative threshold do not apply to immaterial items. That is, an entity does not need to separately disclose the required specific categories or reconciling items if they are immaterial, even if the quantitative threshold is met."</u>*

Solely for the purpose of demonstrating to the Staff the immateriality of amounts involved, we provide below a rate reconciliation that breaks out "Effect of cross-border tax laws" from "Other Adjustments", showing that the dollar impact for each year was immaterial to the overall financial statements, and we deemed it immaterial for separate disclosure in the reconciliation when considering the guidance in ASC 105 as discussed in BC22 within ASU 2023-09. The impact for years 2025 through 2023 for the "Effect of cross-border tax laws" was $4.4 million or 2.6%, $3.8 million or 2.3%, and $0.1 million or 0.0% respectively compared to total income tax expense and $4.4 million or 0.1%, $3.8 million or 0.1%, and $0.1 million or 0.0% respectively compared to net income. The impact on the effective tax rate was less than 1% for each year presented.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| <u>Years ended December 31</u> | 2025 | 2025 | 2024 | 2024 | 2023 | 2023 |
| (dollars in millions) |  |  |  |  |  |  |
|  | Dollars | Percentages | Dollars | Percentage | Dollars | Percentages |
| **U.S. federal statutory tax rate** | $150.2 | 21.0% | $147.2 | 21.0% | $154 | 21.0% |
| **State and local income tax, net of federal (national) benefit** | 21.0 | 2.9 | 18.1 | 2.6 | 21.0 | 2.9 |
| **Foreign tax effects** |  |  |  |  |  |  |
| &nbsp;&nbsp;China |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax benefit from research anddevelopment expenditures | (8.5) | (1.2) | (7.9) | (1.1) | (10.1) | (1.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 4.2 | 0.6 | 3.2 | 0.5 | 5.3 | 0.7 |
| &nbsp;&nbsp;Other foreign jurisdictions | 6.8 | 1.0 | 1.5 | 0.2 | 6.2 | 0.9 |
| **Effect of cross-border tax laws** | (4.4) | (0.6) | 3.8 | 0.5 | 0.1 |  |
| **Other Adjustments** | (0.4) | (0.1) | 1.5 | 0.2 | 0.4 |  |
|  | $168.9 | 23.6% | $167.4 | 23.9% | $176.9 | 24.1% |

---

As a result, we respectfully advise the Staff that we do not believe it is necessary to break out the "Effect of cross-border tax laws" from "Other Adjustments" in the reconciliation due to the immateriality of the amounts involved in all periods presented. To the extent amounts become material in future filings, we will separately disclose the effect of cross-border tax laws.

In connection with our response, we acknowledge that we are responsible for the accuracy and adequacy of our disclosures, notwithstanding any review, comments, action or absence of action by the Staff.

If you have any questions or require additional information with respect to the foregoing, please contact Charles Lauber at (414) 359-4076 or clauber@aosmith.com.

Sincerely,

<u>/s/ Charles T. Lauber</u> 

Charles T. Lauber

Executive Vice President & Chief Financial Officer

cc:&nbsp;&nbsp;&nbsp;&nbsp;Paul J. Jones, Senior Vice

President and General Counsel,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. O. Smith

Benjamin A. Otchere, Vice President

and Controller A. O. Smith

Patrick G. Quick, Foley & Lardner LLP

<br>